Study Stopped
Recruitment pace was not sufficient to support fully-powered efficacy trial. Study investigators decided to terminate the feasibility trial before reaching recruitment target.
Meals 4 Moms: A Multilevel Community-based Lifestyle Intervention for GDM
Meals 4 Moms: Development and Feasibility of a Multilevel Community-based Lifestyle Intervention for Gestational Diabetes
1 other identifier
interventional
8
1 country
1
Brief Summary
The goal of the project is to conduct a pilot feasibility randomized trial comparing a community-based lifestyle intervention called Meals for Moms (M4M) versus the usual care for pregnant persons diagnosed with gestational diabetes (GDM). Participants will be randomly placed into the usual care (UC) comparison group or the M4M healthy living program, which includes continued GDM education, physical activity level monitoring, and delivery of medically-tailored GDM meals. The trial will assess if M4M is feasible for the management of gestational diabetes in pregnant patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2024
CompletedFirst Posted
Study publicly available on registry
January 26, 2024
CompletedStudy Start
First participant enrolled
March 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 7, 2025
CompletedResults Posted
Study results publicly available
February 17, 2026
CompletedMay 5, 2026
April 1, 2026
10 months
January 17, 2024
January 22, 2026
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Acceptability (Participate Again)
Percent of participants who report they would be likely or very likely to participate again if they had gestational diabetes (GDM) again.
Follow-Up (aim: within 2 weeks post-delivery)
Acceptability (Recommended)
Percent of participants who report they would be likely to very likely to recommend the M4M intervention to a friend with gestational diabetes (GDM).
Follow-Up (aim: within 2 weeks post-delivery)
Recruitment
Recruitment rates will be calculated from the number of patients approached and reasons for ineligibility and non-participation.
Baseline
Retention
Percent of participants who complete any aspect of the follow-up assessment.
Follow-Up (aim: within 2 weeks post-delivery)
Receipt of Intervention (Meal Ordering)
Percent of participants who spent at least 80% of weekly $266 food budget.
Follow-Up (aim: within 2 weeks post-delivery)
Receipt of Intervention (Exercise Session Completion)
Percent of participants who completed at least 80% of exercise sessions they were eligible to complete.
Follow-Up (aim: within 2 weeks post-delivery)
Study Arms (2)
Meals 4 Moms intervention
EXPERIMENTALParticipants randomized to the M4M condition will receive: * Food budget of $266 per week in credits to spend towards medically-tailored GDM meals * Enhanced educational GDM-specific education on exercise, nutrition, and blood sugar glucose management * Activity tracker and digital scale * Usual GDM care
Usual GDM Care
NO INTERVENTIONUsual care (UC) will consist of the current treatment care that is provided by the participant's prenatal care provider. Usual care consists of a special diet, monitoring of blood glucose levels and encouragement/guidance of increasing a participant's exercise.
Interventions
A community-based, healthy living program including continued gestational diabetes (GDM) education, physical activity level monitoring, and delivery of medically-tailored GDM meals for the management of gestational diabetes in pregnant people.
Eligibility Criteria
You may qualify if:
- years old
- Current singleton pregnancy
- GDM diagnosis between 24+0 and 31+6 weeks gestation, and no more than 4weeks from time of diagnosis at time of enrollment.
- Currently receiving gestational diabetes management at the UConn Health Maternal Fetal Clinic, St. Francis's Hospital Women's Health clinic, Hartford Healthcare Women's Ambulatory Health Services (WAHS)
- Intends to deliver at either UConn Health, St. Francis Hospital or Hartford Healthcare
- Able to read and understand English well enough to participate in the study in English
- Daily access to the internet from smartphone, tablet computer, or laptop/desktop computer that they can use to participate in the study
- Medical clearance to participate from prenatal care provider including clearance to engage in physical activity
- Able to provide verbal or written consent for each component of the study procedures and data collection
- Currently lives within one of the meal delivery areas in Connecticut to allow for meal delivery (total of 32 eligible towns/cities)
You may not qualify if:
- Unable or unwilling to give informed consent or communicate with study staff.
- Diabetes mellitus (Type I or Type II).
- GDM diagnosed prior to 24 weeks gestation or after 32+0 weeks gestation.
- Patient is scheduled for a preterm delivery for medical reasons (i.e., placenta accreta, prior classical incision) at time of eligibility screening or at any time prior to randomization.
- Concurrent participation in another research study providing intervention related to GDM, pregnancy, diet, and/or physical activity.
- Medical conditions that may result in the inability to tolerate solid foods (i.e., hyperemesis gravidarum).
- Medical condition which would prohibit participation as indicated by prenatal care provider providing medical clearance.
- Dietary restrictions that cannot be accommodated for during meal preparation.
- Currently does not live in one of the towns listed within the meal delivery area.
- Has plans to move to out of the meal delivery area between enrollment and expected pregnancy due date.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Trinity Health Of New Englandcollaborator
- Hartford Hospitalcollaborator
- UConn Healthlead
- University of Connecticutcollaborator
Study Sites (1)
UConn Health
Farmington, Connecticut, 06030, United States
Related Publications (20)
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005 Jun 16;352(24):2477-86. doi: 10.1056/NEJMoa042973. Epub 2005 Jun 12.
PMID: 15951574BACKGROUNDCosson E, Baz B, Gary F, Pharisien I, Nguyen MT, Sandre-Banon D, Jaber Y, Cussac-Pillegand C, Banu I, Carbillon L, Valensi P. Poor Reliability and Poor Adherence to Self-Monitoring of Blood Glucose Are Common in Women With Gestational Diabetes Mellitus and May Be Associated With Poor Pregnancy Outcomes. Diabetes Care. 2017 Sep;40(9):1181-1186. doi: 10.2337/dc17-0369. Epub 2017 Jul 19.
PMID: 28724718BACKGROUNDHAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008 May 8;358(19):1991-2002. doi: 10.1056/NEJMoa0707943.
PMID: 18463375BACKGROUNDLandon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009 Oct 1;361(14):1339-48. doi: 10.1056/NEJMoa0902430.
PMID: 19797280BACKGROUNDBerggren EK, Mele L, Landon MB, Spong CY, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Sciscione A, Catalano P, Harper M, Saade G, Caritis SN, Sorokin Y, Peaceman AM, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes. Obstet Gynecol. 2012 Nov;120(5):1099-104. doi: 10.1097/aog.0b013e31827049a5.
PMID: 23090528BACKGROUNDHartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med. 2013 Jul 16;159(2):123-9. doi: 10.7326/0003-4819-159-2-201307160-00661.
PMID: 23712381BACKGROUNDChan CWH, Au Yeung E, Law BMH. Effectiveness of Physical Activity Interventions on Pregnancy-Related Outcomes among Pregnant Women: A Systematic Review. Int J Environ Res Public Health. 2019 May 23;16(10):1840. doi: 10.3390/ijerph16101840.
PMID: 31126153BACKGROUNDGarcia-Patterson A, Martin E, Ubeda J, Maria MA, de Leiva A, Corcoy R. Evaluation of light exercise in the treatment of gestational diabetes. Diabetes Care. 2001 Nov;24(11):2006-7. doi: 10.2337/diacare.24.11.2006. No abstract available.
PMID: 11679479BACKGROUNDAvery MD, Walker AJ. Acute effect of exercise on blood glucose and insulin levels in women with gestational diabetes. J Matern Fetal Med. 2001 Feb;10(1):52-8. doi: 10.1080/714904296.
PMID: 11332421BACKGROUNDCoe DP, Conger SA, Kendrick JM, Howard BC, Thompson DL, Bassett DR Jr, White JD. Postprandial walking reduces glucose levels in women with gestational diabetes mellitus. Appl Physiol Nutr Metab. 2018 May;43(5):531-534. doi: 10.1139/apnm-2017-0494. Epub 2017 Dec 22.
PMID: 29272606BACKGROUNDOnaade O, Maples JM, Rand B, Fortner KB, Zite NB, Ehrlich SF. Physical activity for blood glucose control in gestational diabetes mellitus: rationale and recommendations for translational behavioral interventions. Clin Diabetes Endocrinol. 2021 Apr 25;7(1):7. doi: 10.1186/s40842-021-00120-z.
PMID: 33896420BACKGROUNDCox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987 Jun;150:782-6. doi: 10.1192/bjp.150.6.782.
PMID: 3651732BACKGROUNDWeiss BD, Mays MZ, Martz W, Castro KM, DeWalt DA, Pignone MP, Mockbee J, Hale FA. Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med. 2005 Nov-Dec;3(6):514-22. doi: 10.1370/afm.405.
PMID: 16338915BACKGROUNDHanson MA, Bardsley A, De-Regil LM, Moore SE, Oken E, Poston L, Ma RC, McAuliffe FM, Maleta K, Purandare CN, Yajnik CS, Rushwan H, Morris JL. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: "Think Nutrition First". Int J Gynaecol Obstet. 2015 Oct;131 Suppl 4:S213-53. doi: 10.1016/S0020-7292(15)30034-5. No abstract available.
PMID: 26433230BACKGROUNDChen TC, Clark J, Riddles MK, Mohadjer LK, Fakhouri THI. National Health and Nutrition Examination Survey, 2015-2018: Sample Design and Estimation Procedures. Vital Health Stat 2. 2020 Apr;(184):1-35.
PMID: 33663649BACKGROUNDSubar AF, Kirkpatrick SI, Mittl B, Zimmerman TP, Thompson FE, Bingley C, Willis G, Islam NG, Baranowski T, McNutt S, Potischman N. The Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute. J Acad Nutr Diet. 2012 Aug;112(8):1134-7. doi: 10.1016/j.jand.2012.04.016. Epub 2012 Jun 15. No abstract available.
PMID: 22704899BACKGROUNDVandelanotte C, Spathonis KM, Eakin EG, Owen N. Website-delivered physical activity interventions a review of the literature. Am J Prev Med. 2007 Jul;33(1):54-64. doi: 10.1016/j.amepre.2007.02.041.
PMID: 17572313BACKGROUNDHsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005 Nov;15(9):1277-88. doi: 10.1177/1049732305276687.
PMID: 16204405BACKGROUNDHudson J, Nguku SM, Sleiman J, Karlen W, Dumont GA, Petersen CL, Warriner CB, Ansermino JM. Usability testing of a prototype Phone Oximeter with healthcare providers in high- and low-medical resource environments. Anaesthesia. 2012 Sep;67(9):957-67. doi: 10.1111/j.1365-2044.2012.07196.x.
PMID: 22861503BACKGROUNDHordern MD, Dunstan DW, Prins JB, Baker MK, Singh MA, Coombes JS. Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia. J Sci Med Sport. 2012 Jan;15(1):25-31. doi: 10.1016/j.jsams.2011.04.005. Epub 2011 May 28.
PMID: 21621458BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Molly Waring (study statistician)
- Organization
- University of Connecticut
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Shields, MD, MS
UConn Health
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 17, 2024
First Posted
January 26, 2024
Study Start
March 5, 2024
Primary Completion
December 16, 2024
Study Completion
January 7, 2025
Last Updated
May 5, 2026
Results First Posted
February 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share